Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2491 - Outcomes Following Proton Radiation for Pediatric Meningiomas
Speaker: Thompson, Elizabeth, MD, BS - University of Florida, Gainesville, FL
4:45 PM - 6:00 PM PT

2492 - Cardiac Risk, Outcomes, and Management among Older Adults with Stage I-II NSCLC Undergoing Stereotactic Body Radiation Therapy
Speaker: Shah, Sanjana, BS - Harvard Medical School, Boston, MA
4:45 PM - 6:00 PM PT

2493 - Prospective Validation of a Pretreatment 18F FDG PET CT plus Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Consolidation Immunotherapy
Speaker: Deasy, Joseph, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
4:45 PM - 6:00 PM PT

2494 - Bayesian Model-Based Internal Target Volume Accounting for Interfractional Hilum Shifts during Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Speaker: Ueki, Kazuhito, MD, PhD - National Hospital Organization Kyoto Medical Center, Kyoto, Fushimiku
4:45 PM - 6:00 PM PT

2495 - Toxicity Profile for Connective Tissue Disease Patients Treated with Lung Stereotactic Body Radiation Therapy (SBRT)
Speaker: Ufondu, Adannia, MD, BA - Cleveland Clinic, Cleveland, OH
4:45 PM - 6:00 PM PT

2496 - Imaging and Clinical Outcomes following Definitive Radiation Therapy for Children with High-Grade Glioma
Speaker: Unnikrishnan, Soumya, MD, MS - Winship Cancer Institute of Emory University, Atlanta, GA
4:45 PM - 6:00 PM PT

2497 - Prospective Patient-Reported Outcomes (PRO) Regarding Skin Toxicity from Hypo-Fractionated Regional Nodal Irradiation (RNI) following Mastectomy and Lumpectomy
Speaker: Varghese, Sunitha, MD, MBBS - The University of Kansas Health System, Kansas city, Kansas
4:45 PM - 6:00 PM PT

2498 - Preparation of mRNA-LNP Vaccine Based on HER2 Target and Its Antitumor Effect in Combination with Radiotherapy in Lung Cancer
Speaker: Wang, Jun, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
4:45 PM - 6:00 PM PT

2499 - Real-World Study on the Efficacy, Safety, and Prognostic Analysis of Chemotherapy Combined with Immunotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer
Speaker: Wang, Jun, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
4:45 PM - 6:00 PM PT

2500 - Biomarker Analysis of Iruplinalkib Combined with Chemoradiotherapy in ALK+ Unresectable Stage ? Non-Small Cell Lung Cancer
Speaker: Wang, Linlin, MD, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
4:45 PM - 6:00 PM PT

2501 - Cranial Radiotherapy Improves Survival in Brain Metastatic NSCLC Patients Bearing EGFR and TP53 Mutations
Speaker: WANG, LU, MD, PhD - Department of radiotherapy oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, chongqing
4:45 PM - 6:00 PM PT

2502 - Clinical and Dosimetric Predictors of Radiation Pneumonitis in Pathologic Stage III-N2 Non-Small Cell Lung Cancer Patients Receiving Postoperative Radiotherapy Following Lobectomy: An Analysis of a Prospective Cohort
Speaker: Wang, Nengyang, MD - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai, Shanghai